Implementation of a novel interdisciplinary pharmacology curriculum in a hematology/oncology fellowship program.

9028 Background: Thoroughly understanding cancer therapeutics is a critical component of Hematology/Oncology (HO) training, with pharmacology comprising a large part of the ASCO/ESMO Recommendations for a Global Medical Oncology Curriculum. Prior studies demonstrated that interdisciplinary approaches to education lead to more teamwork and enable learners to gain from multiple perspectives. We created and implemented a novel pharmacology curriculum in our HO fellowship program using a case-based, interdisciplinary format grounded in learning science principles. Methods: We used a pre-post design to evaluate and transform HO fellowship pharmacology training. The pre-existing pharmacology curriculum was organized by drug mechanism of action (MOA) and delivered via a didactic lecture by a pharmacist. HO fellows completed a baseline survey assessing satisfaction and garnering feedback. Based on this feedback, a case-based curriculum was piloted, organized by disease type and given jointly by a pharmacist and clinician. Lectures involved active learning with call and response questions with guidance in treatment decision making, dosing considerations, patient counseling, and toxicity management. This was followed by a post-survey to assess changes in perceptions and effectiveness. Results: 34% of HO fellows filled out the initial survey (11/32) and 17 (53%) completed the post-lecture survey with results in Table 1. Among the 12 post-survey respondents who had attended pharmacology lectures the previous year, all rated the new format as an improvement. Thematic qualitative analysis emphasized increased absorption of material and increased relevance due to clinician inclusion and case-based format. Comments noted the new series as a “marked improvement” and “more clinically relevant.” Conclusions: HO fellows found a case-based, interdisciplinary, disease-specific pharmacology curriculum conducive to learning and retaining information, and a significant improvement over a passive lecture series organized by MOA. The new format increased fellows’ confidence and abilities in managing cancer-directed therapies, and improved perceived skills related to interdisciplinary patient care. This curriculum could serve as a model for implementation at HO fellowship programs in other institutions. Pre- and post-intervention survey results. Pre-survey statement % Agree, n/total I did not retain a significant amount from the lectures 63%, 7/11 I did not find the format conducive to learning 73%, 8/11 I would prefer a case-based approach 91%, 10/11 Post-survey statement The new format is conducive to my learning 94%, 16/17 The interdisciplinary format enhanced my learning 94%, 16/17 The lectures increased my confidence in prescribing/ managing therapies 88%, 15/17 The lectures improved my ability to discuss treatment options with patients/other providers 71%, 12/17

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.9028
Primary Topic
Biomedical and Engineering Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementation of a novel interdisciplinary pharmacology curriculum in a hematology/oncology fellowship program.

Tendai Kwaramba, Thejal Srikumar, Rambon Shamilov, Sarah B. Goldberg et al.
Journal of Clinical Oncology
Biomedical and Engineering Education
article

Implementation of a novel interdisciplinary pharmacology curriculum in a hematology/oncology fellowship program.

Tendai Kwaramba, Thejal Srikumar, Rambon Shamilov, Sarah B. Goldberg, Alfred Ian Lee, Rebecca Forman
article en

Abstract

9028 Background: Thoroughly understanding cancer therapeutics is a critical component of Hematology/Oncology (HO) training, with pharmacology comprising a large part of the ASCO/ESMO Recommendations for a Global Medical Oncology Curriculum. Prior studies demonstrated that interdisciplinary approaches to education lead to more teamwork and enable learners to gain from multiple perspectives. We created and implemented a novel pharmacology curriculum in our HO fellowship program using a case-based, interdisciplinary format grounded in learning science principles. Methods: We used a pre-post design to evaluate and transform HO fellowship pharmacology training. The pre-existing pharmacology curriculum was organized by drug mechanism of action (MOA) and delivered via a didactic lecture by a pharmacist. HO fellows completed a baseline survey assessing satisfaction and garnering feedback. Based on this feedback, a case-based curriculum was piloted, organized by disease type and given jointly by a pharmacist and clinician. Lectures involved active learning with call and response questions with guidance in treatment decision making, dosing considerations, patient counseling, and toxicity management. This was followed by a post-survey to assess changes in perceptions and effectiveness. Results: 34% of HO fellows filled out the initial survey (11/32) and 17 (53%) completed the post-lecture survey with results in Table 1. Among the 12 post-survey respondents who had attended pharmacology lectures the previous year, all rated the new format as an improvement. Thematic qualitative analysis emphasized increased absorption of material and increased relevance due to clinician inclusion and case-based format. Comments noted the new series as a “marked improvement” and “more clinically relevant.” Conclusions: HO fellows found a case-based, interdisciplinary, disease-specific pharmacology curriculum conducive to learning and retaining information, and a significant improvement over a passive lecture series organized by MOA. The new format increased fellows’ confidence and abilities in managing cancer-directed therapies, and improved perceived skills related to interdisciplinary patient care. This curriculum could serve as a model for implementation at HO fellowship programs in other institutions. Pre- and post-intervention survey results. Pre-survey statement % Agree, n/total I did not retain a significant amount from the lectures 63%, 7/11 I did not find the format conducive to learning 73%, 8/11 I would prefer a case-based approach 91%, 10/11 Post-survey statement The new format is conducive to my learning 94%, 16/17 The interdisciplinary format enhanced my learning 94%, 16/17 The lectures increased my confidence in prescribing/ managing therapies 88%, 15/17 The lectures improved my ability to discuss treatment options with patients/other providers 71%, 12/17

Journal of Clinical OncologyVol. 43(16_suppl)
Yale New Haven Hospital (US), Yale Cancer Center (US), Yale University (US)
Openalex Percentile: Top 89%
Biomedical and Engineering Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.